Doctor profile · Federal record

Dr. Mark Abate, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Santa Barbara, CA

  • NPI 1588778674
  • Accepts Medicare
  • 44 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
540 W Pueblo St
Santa Barbara, CA 931054230
(805) 879-0670
Additional location
317 W Pueblo St
Santa Barbara, CA 931054355
(805) 681-1761
fax (805) 681-1768
Mailing address
Po Box 62106
Santa Barbara, CA 931602106

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
January 28, 2019
Year of graduation
1982 — 44 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #G55892
Medicaid
CA #00G558920

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1588778674. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,584
Distinct HCPCS
10
Medicare allowed
$165,881
HCPCS Description Services Patients Avg allowed
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,316 15 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 558 236 $136
J2469 Injection, palonosetron hcl, 25 mcg 500 12 $1
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 312 49 $81
96413 Administration of chemotherapy into vein, 1 hour or less 195 25 $150
96375 Injection of additional new drug or substance into vein 150 16 $17
96372 Injection of drug or substance under skin or into muscle 127 18 $15
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 85 19 $73
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 77 14 $33
36591 Collection of blood sample from implanted device 66 19 $31

In context: peer comparison

Among 6 peers in this city , average services per provider: 914. This provider delivers 3.9× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,152
Transactions
87
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 12 $667.59
Janssen Biotech, Inc. 12 $363.44
AstraZeneca Pharmaceuticals LP 7 $336.25
E.R. Squibb & Sons, L.L.C. 5 $320.90
Sekisui Diagnostics, LLC 1 $300.00
SOBI, INC 6 $261.41
Gilead Sciences, Inc. 6 $231.41
Astellas Pharma US Inc 10 $219.85
Lilly USA, LLC 3 $214.69
Alexion Pharmaceuticals, Inc. 3 $183.95
ABBVIE INC. 4 $176.26
Apellis Pharmaceuticals, Inc. 3 $174.52
PFIZER INC. 12 $143.15
Alnylam Pharmaceuticals Inc. 1 $133.90
Agios Pharmaceuticals, Inc. 2 $92.25

By nature of payment

Food and Beverage
$3,324
Long term medical supply or device loan
$499
Gift
$300
Education
$30

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
287
Patients
16
Total drug cost
$261,976
Drug Type Claims Patients Total cost
Anastrozole Generic 59 16 $1,601
Acyclovir Generic 30 0 $782
Eliquis (Apixaban) Brand 29 0 $27,083
Tamoxifen Citrate Generic 27 0 $650
Xarelto (Rivaroxaban) Brand 25 0 $27,287
Prednisone Generic 19 0 $141
Dexamethasone Generic 17 0 $330
Levothyroxine Sodium Generic 16 0 $236
Pantoprazole Sodium Generic 16 0 $138
Bicalutamide Generic 13 0 $1,234

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Abate's medical specialty?
Dr. Mark Abate practices Hematology & Oncology Physician in Santa Barbara, CA.
Where does Dr. Mark Abate practice?
Dr. Mark Abate practices at 540 W Pueblo St, Santa Barbara, CA 931054230. Office phone: 8058790670.
What is Dr. Mark Abate's NPI?
Dr. Mark Abate's National Provider Identifier (NPI) is 1588778674, issued by NPPES.
Does Dr. Mark Abate accept Medicare assignment?
Yes. Dr. Mark Abate accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Abate commonly perform?
Top Medicare-reported procedures in 2023: Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Established patient office or other outpatient visit (HCPCS 99214); Injection, palonosetron hcl, 25 mcg (HCPCS J2469). Source: CMS Medicare Physician & Other Practitioners file.